"An established clinical research site that conducts various clinical trials from phase 1 studies to phase 4 studies with an emphasis on Nephrology, Gastroenterology, Cardiology and General Medicine. Fully staffed with physicians, physician assistants, registered nurses, certified phlebotomist; all of which are GCP and IATA trained and certified."

During the past decade, Valiance Clinical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Valiance Clinical Research" are "Hypertension" (2 trials), "ADPKD" (1 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Kidney Disease, Chronic" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Valiance Clinical Research" in a lesser frequency.

Most popular intervention types in "Valiance Clinical Research" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg" (2 trials), "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "BI 764198" (1 trials) and "RGLS8429" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valiance Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Valiance Clinical Research". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Valiance Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Valiance Clinical Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".